M
aintaining energy homeostasis depends on multiple organs, including the brain, pancreas, liver, skeletal muscle, and adipose tissue. In times of energy excess, skeletal muscle and adipose tissue are the 2 main peripheral organs involved in the storage of macronutrients in the form of glycogen and triglycerides, respectively. 1 The anabolic hormone insulin, released by the pancreatic β-cells after food ingestion, stimulates energy storage by promoting the uptake of dietary sugar and fat. 2 The delivery of macronutrients to target organs, such as skeletal muscle and adipose tissue, depends greatly on adequate perfusion. 3 Interestingly, in the early 90s, it has been demonstrated that insulin itself affects skeletal muscle perfusion. 4, 5 In healthy individuals, insulin enhances skeletal muscle perfusion via insulin signaling pathways in the endothelial cell, which result in nitric oxide production and consequently vasodilatation of precapillary arterioles. 5 Increased postprandial skeletal muscle perfusion facilitates the delivery of nutrients to the myocyte and contributes to ≤40% 6 of wholebody glucose uptake by stimulating translocation of glucose and insulin into the muscle interstitial space. 7 However, in several acute 8, 9 and chronic 10 states of insulin resistance, insulin-mediated skeletal muscle perfusion is impaired and is associated with impaired whole-body glucose uptake. 11, 12 Furthermore, impaired insulin signaling in the endothelial cell has been identified as an early event during high-fat feeding in mice because microvascular insulin resistance develops before metabolic insulin resistance. [13] [14] [15] These data suggest that the inability of insulin to cause vasodilation and delivery of substrates to peripheral tissues, especially in the postprandial state, plays a part in the development of impaired insulinstimulated muscle and whole-body glucose uptake. 16 Although the pathophysiological role of adipose tissue in the development of whole-body insulin resistance has gained much attention over the last decades, it is unknown whether impaired adipose tissue perfusion is a relevant contributor. Recent reviews have addressed adipose tissue perfusion in healthy and insulinresistant individuals and have proposed several underlying vasoregulatory mechanisms involved. 17, 18 This current review focuses specifically on the possible role of adipose tissue perfusion in the development of whole-body insulin resistance.
Adipose Tissue Perfusion in Healthy Individuals
tomography. 19 Measurements of adipose tissue perfusion can entail both blood flow (in mL/min) and blood volume (in mL) and depend on the method that is used. Blood flow is the product of blood volume and blood velocity, 20, 21 implying that an increase in blood flow can result from either an increase in blood volume or an increase in blood velocity. The most common method to measure adipose tissue blood flow (ATBF) is the xenon washout method, which is considered the gold standard. Washout kinetics after the injection of the radioactive isotope 133 Xe have been applied in various forms to measure total microvascular ATBF. The technique is based on the principle that the clearance of a substance injected into a tissue depends on microvascular blood flow through the tissue. 22, 23 Using this technique, it has been shown that fasting ATBF is similar to the blood flow in resting skeletal muscle, ≈3 mL/min per 100 g. 24 In addition, it has been demonstrated that postprandial subcutaneous adipose tissue perfusion-measured after a mixed meal or oral glucose load-is increased ≤4-fold in lean insulinsensitive individuals. 11, 24 The fact that ATBF rises after nutrient ingestion suggests that insulin might not only be a regulator of skeletal muscle, but also of adipose tissue perfusion.
The Physiology of Insulin on Adipose Tissue Perfusion
The in vivo effects of insulin per se on adipose tissue perfusion, separate from other hormones released after ingestion of food, can be best examined during the hyperinsulinemiceuglycemic clamp method (ie, plasma insulin concentration is raised to postprandial levels through exogenous administration, and glucose concentration is clamped at 90 mg/dL). Several elegant studies demonstrated that ATBF also rises during this clamp procedure using the xenon washout 25 and positron emission tomography 19 methods. Furthermore, measurements of adipose tissue microvascular blood volume by means of contrast-enhanced ultrasonography in healthy females revealed a 30% increase on insulin infusion. 26 The positive correlation between the rise in ATBF and the maximum insulin concentration and the temporal relationship between the increase in plasma insulin concentrations and ATBF are considered evidence of a regulatory role of insulin in this process. 18, 25 In contrast to the local effects of insulin on endothelial cells of skeletal muscle arterioles, 27 the insulin-mediated stimulation of adipose tissue perfusion is most likely an indirect systemic effect because local infusion of insulin by adipose tissue microinfusion did not influence ATBF. 18 Adipose tissue microinfusion combines the xenon washout technique with local infusion of pharmacological agents in the same depot and allows for measurements of local effects, whereas contralateral infusion of isotonic saline functions as placebo control. 25, [28] [29] [30] [31] Interestingly, the insulin receptor, its main docking proteins, and several downstream signaling proteins are expressed in human microvascular endothelial cells isolated from adipose tissue samples. However, endothelial nitric oxide synthase (eNOS) protein and gene expression are almost undetectable, and insulin has no appreciable effect on the expression of eNOS mRNA. 32 This is in agreement with the results from Ardilouze et al, 29 who demonstrated that infusion of l-N Gmonomethyl arginine-a nonselective NOS inhibitor-prior to an oral glucose load does not attenuate the postprandial rise of adipose tissue perfusion in healthy individuals. In contrast, postprandial perfusion of skeletal muscle is impaired by l-N G -monomethyl arginine infusion, indicating a nitric oxide-dependent mechanism. 30 The observations that infusion of the nonselective β-blocker propranolol blunts the postprandial ATBF response by 58%, 29 and infusion of the β-agonist isoproterenol augments ATBF in a dose-dependent manner, 31 suggest that meal-induced increase in ATBF are principally regulated via β-adrenergic stimuli. In line with these findings, studies in both rodents and humans have shown that insulin enhances sympathetic nervous system activity, which results in outflow of noradrenalin via postganglionic sympathetic fibers. Furthermore, insulin crosses the blood-brain barrier, and insulin receptors have been found to be located in several areas of the brain. 33 There is evidence to suggest that insulin may initiate sympathoactivation through the central nervous system, 34 in particular via the paraventricular nucleus of the hypothalamus. 35 It has been additionally demonstrated that glucose ingestion, a mixed meal, and a hyperinsulinemic-euglycemic clamp all result in higher sympathetic nerve activity, higher regional noradrenalin spillover, and higher plasma levels of noradrenalin. [36] [37] [38] Thus, insulin could increase ATBF via both humoral and neural stimulation of β-1-adrenergic receptors. In contrast to the data summarized above, functional wire and pressure myography experiments using isolated arterioles from human and rodent abdominal subcutaneous adipose tissue indicated that insulin does exert a direct vasodilator effect (Bakker et al, unpublished data, 2009). 39 Moreover, this effect seems to be exerted via known insulin signaling proteins-insulin receptor substrate 1, Akt, eNOS-and is nitric oxide dependent, 39 which is in contradiction with previous mentioned observation in microvascular endothelial cells. However, the experiments with mice arterioles concern first-order arterioles, and the size of the arterioles in the human experiments (ie, internal diameter 220±40 μm) also suggests that these arterioles are resistance vessels and not precapillary arterioles. These findings may, therefore, be of more relevance to blood pressure regulation than to adipose tissue perfusion. This could explain the discrepancy in outcome from the in vivo and ex vivo studies concerning a direct or indirect insulin effect.
To summarize, based on the currently available data, insulin augments postprandial ATBF, likely in an indirect manner through stimulation of β-adrenergic receptors in adipose tissue arterioles. The presence of an insulin receptor on microvascular endothelial cells in adipose tissue could serve other insulin-mediated processes, such as transendothelial transport of insulin. 40 However, a direct effect of insulin cannot be completely ruled out.
ATBF in Obesity, Insulin Resistance, and Type 2 Diabetes Mellitus
In obese and type 2 diabetes mellitus (T2DM) patients, the postprandial increase in ATBF is blunted, 19, 41, 42 despite increased postprandial plasma insulin concentrations. 11 Although the postprandial increase in ATBF is negatively correlated with body mass index (r −0.57, P<0.05) in study participants with a body mass index ranging from 19.4 to 29.6 kg/m 2 , 43 there seems to be an even stronger inverse association with the degree of insulin resistance and glucose intolerance. For example, ATBF responsiveness to food ingestion is decreased in lean insulin-resistant first-degree relatives of T2DM patients, 44 compared with weight-matched insulin-sensitive individuals. In addition, postprandial ATBF is impaired in obese, glucose-tolerant individuals, but completely abolished in obese, weight-matched, glucose-intolerant individuals. 43 Interestingly, incremental doses of isoproterenol exhibit a dose-dependent ATBF response in individuals with a high ATBF response to an oral glucose load, whereas individuals with a low ATBF response fail to react. This indicates that the lack of postprandial responsiveness of adipose tissue perfusion seems to depend on a reduced response to β-adrenergic stimuli. 31 This reduced response may be the results of downregulation of adrenergic receptors, possibly caused by continuous sympathetic overstimulation because of insulin resistance-induced hyperinsulinemia, or could entail impaired postreceptor signaling.
Role of Impaired ATBF in the Development of Whole-Body Insulin Resistance
The inverse association between postprandial rise in adipose tissue perfusion with the degree of insulin resistance, suggest that impaired ATBF may affect whole-body insulin sensitivity. Impaired postprandial adipose tissue perfusion could lead to reduced delivery of glucose, lipids, and oxygen toward adipose tissue, which consequently may result in decreased glucose uptake, ectopic lipid accumulation, and hypoxia. These metabolic consequences of impaired adipose tissue perfusion will be detailed further.
Glucose Uptake in Adipose Tissue
In insulin-sensitive individuals, adipose tissue is responsible for only a small portion (<10%) of whole-body glucose uptake. 19, 45 In insulin-resistant states, particularly, impaired skeletal muscle glucose uptake accounts for the reduction in insulin-stimulated whole-body glucose uptake, whereas impaired glucose uptake in adipose tissue does not seem to contribute substantially. 19 These observations suggest that adipose tissue glucose uptake is insignificant in postprandial glucose disposal. However, it has been demonstrated that mice with adipose-selective reduction of glucose transporter-4 (G4A −/− ) develop muscle and liver insulin resistance, that is, a reduced insulin-stimulated whole-body glucose uptake and decreased insulin-stimulated suppression of endogenous glucose production. 46 Of note, in these GA4 −/− mice, insulinstimulated transport of glucose into the skeletal muscle was impaired in vivo, whereas the expression of glucose transporter 4 and glucose uptake in vitro was preserved. 46 This implies that defective insulin-stimulated skeletal muscle glucose uptake is likely secondary to deteriorations of the in vivo milieu, such as alterations in the production of adipokines or the release of proinflammatory cytokines from adipose tissue. In more recent decades, adipose tissue has indeed been recognized as an active endocrine organ. As an alternative, adipose tissue glucose disposal may be more essential than expected and may compensate for a reduction in skeletal muscle glucose uptake. Interestingly, muscle-specific insulin receptor knockout mice do not exhibit hyperglycemia, hyperinsulinemia, or impaired glucose tolerance, 47 and insulinstimulated glucose uptake in the skeletal muscle is decreased by 80%, whereas insulin-stimulated glucose uptake in fat tissue is increased 3-fold. 48 In humans, Virtanen et al measured adipose tissue glucose uptake by means of [ 18 F]-fluorodeoxyglucose positron emission tomography in lean, obese, and T2DM patients. They demonstrated that adipose tissue glucose uptake is lower in obese and T2DM patients when compared with lean insulinsensitive individuals when expressed per kilogram fat tissue. However, when glucose uptake (in μmol/min/kg) was multiplied by adipose tissue mass, total glucose uptake per fat depot was similar irrespective of abdominal fat mass or glucometabolic state. 19, 49 These studies using positron emission tomography scans provide information on perfusion and glucose uptake in subcutaneous adipose tissue and in visceral adipose tissue. Obese (T2DM) patients display lower insulin-stimulated blood flow and insulin-stimulated glucose uptake in both visceral and abdominal subcutaneous fat compared with lean individuals, and no differences between the fat depots were detected. The decrease in glucose uptake when measured per kilogram fat tissue can be attributed to insulin resistance at adipocyte level. Previous in vitro studies have demonstrated that adipocytes from obese individuals and T2DM patients are resistant to the effect of insulin to increase glucose uptake. 19, 50 Impaired ATBF may also contribute to decreased glucose uptake per kilogram fat because ATBF (in mL/min per kg) is lower in obese versus nonobese individuals. In addition, insulin-stimulated adipose tissue glucose uptake correlated with the rates of insulin-stimulated ATBF in abdominal subcutaneous adipose tissue (r=0.60, P<0.01) and visceral adipose tissue (r=0.55, P<0.05). 19 Similar to glucose uptake, the enhanced fat mass in obesity compensated for ATBF when measured per depot. As expected, total ATBF per depot was higher in obese than in nonobese individuals. This may imply that in obesity, adipose tissue perfusion is relatively more preserved than adipose tissue glucose uptake.
In conclusion, insulin-stimulated ATBF is reduced in obesity and may contribute to decreased glucose uptake per kilogram fat tissue. However, in vitro studies also suggest a role for cellular postreceptor insulin signaling defects in the reduction of adipose tissue glucose uptake. Moreover, impairments in adipose tissue glucose uptake do not directly affect whole-body glucose uptake because the expanded fat mass compensates for the reduction in glucose uptake on a per gram tissue basis.
Ectopic Lipid Accumulation
Ectopic lipid accumulation has often been designated as the driving mechanism behind metabolic disturbances leading to skeletal muscle and liver insulin resistance. The so-called overflow hypothesis was proposed by Roger Unger in 2003, 51 which suggests that the inability of adipose tissue to expand and store excess fat leads to deposition of lipids in nonadipose tissues. 52 Previous studies have shown that postprandial triacylglycerol (TAG) clearance in adipose tissue is decreased, 53 and plasma nonesterified fatty acid (NEFA) concentrations are reduced less rapidly by insulin in obese individuals than in those with normal body weight.
11 TAG and NEFA spillover may result in the deposition of ectopic fat in peripheral tissues, such as liver, skeletal muscle, and possibly pancreatic islets. 54 There is some evidence that impaired adipose tissue perfusion affects lipid handling, resulting in postprandial TAG and NEFA spillover. First, both TAGs and NEFAs are nonsoluble in plasma and depend on tissue perfusion for their transport by lipoproteins and albumin, respectively. Second, both postprandial TAG and NEFA concentrations are negatively correlated to the responsiveness of ATBF after a mixed meal. 44, 55 Finally, pharmacological enhancement of ATBF by adrenaline results in increased TAG clearance. 56 Ectopic fat accumulation in the liver, also called liver steatosis or nonalcoholic fatty liver disease, is associated with impaired insulin signaling in the hepatocyte. This hepatic insulin resistance leads to increased endogenous glucose production and decreased glycogen synthesis, both resulting in fasting and postprandial hyperglycemia. It is clear that ectopic fat accumulation interferes with physiological insulin signaling and deteriorates insulin sensitivity of the liver, but whether this is an early deviation in the development of liver and whole-body insulin resistance is still debated. 57 In skeletal muscle tissue, enhanced intramyocellular lipid (IMCL) content is associated with impaired insulin signaling in the myocyte and reduced insulin-mediated glucose uptake. 58, 59 There is evidence that increased IMCL content represents an early abnormality in the development of T2DM. Compared with lean insulin sensitive individuals, first-degree relatives of T2DM patients, who are insulin resistant, but matched for other metabolic features, demonstrated a higher IMCL content. 58 Furthermore, it has been demonstrated that IMCL increases on lipid infusion 60 and decreases after weight loss, 61 in parallel to the expected decrease and increase in insulin sensitivity, respectively, on both interventions. This suggests that increased IMCL may contribute to the defective glucose uptake in insulin-resistant individuals. On the contrary, the positive correlation between IMCL content and skeletal muscle insulin resistance is not a consistent finding. High-endurance athletes have higher IMCL, despite intact insulin sensitivity, a phenomenon termed the athlete's paradox. 62 
Hypoxia
Hypoxia develops with alterations in either decreased oxygen supply or increased oxygen demand, leading to a, relative, oxygen deficit. Reduced oxygen delivery to adipose tissue and subsequent adipose tissue hypoxia have been suggested to drive adipose tissue dysfunction, leading to local and whole-body insulin resistance. In theory, ATBF controls oxygen delivery and may, thus, influence oxygen balance. Indeed, it has been demonstrated that acute changes in ATBF by physiological and pharmacological stimuli in humans result in alterations in oxygen tension in the adipose tissue interstitial space. 63 Furthermore, in mouse models of obesity, adipose tissue hypoxia was observed, which was associated with a proinflammatory phenotype. 64, 65 However, in obese human subjects-with lower corresponding ATBF-data on adipose tissue oxygen tension are less straightforward. Both lower 66 and higher 63 interstitial oxygen tension have been measured in obese individuals. This higher oxygen tension was explained by a reduction in adipose tissue oxygen consumption in the adipose tissue mitochondria of obese individuals compared with lean individuals. Thus, there is no convincing evidence of a causal relationship between impaired ATBF and adipose tissue hypoxia.
Adipose Tissue Perfusion During the Development of Obesity: A Novel Hypothesis
As encapsulated earlier, ATBF is impaired in insulin-resistant states and can be linked to several metabolic derangements. Reduced lipid and glucose uptake as well as hypoxia-as consequences of impaired ATBF-may potentially influence the development of whole-body insulin resistance. However, there is currently no information on the temporal relationship between impaired ATBF and the development of whole-body insulin resistance. In theory, it seems more likely that adipose tissue serves as a sink for excess nutrients during energy excess and that perfusion to adipose tissue is preserved during acute overfeeding. Here we present data that support this hypothesis.
Impaired insulin signaling in endothelial cells seems to be an early defect in the development of obesity-induced insulin resistance and precedes defects in insulin signaling in peripheral tissues. 67 Insulin-mediated Akt and eNOS phosphorylation in thoracic aorta lysates is impaired after only 1 week of high-fat feeding in mice, whereas impairments in insulin signaling in other tissues-such as liver, muscle, and adipose tissue-appear much later in the course of overfeeding, long after changes in body weight and fat percentage are observed. A similar observation of early vascular impairments was made by Zhao et al, 14, 15 who demonstrated significant reduction in Akt and eNOS phosphorylation in the microcirculation before the onset of muscle metabolic insulin resistance as measured by the hyperinsulinemic-euglycemic clamp technique. Because direct insulin-mediated vasodilatation via endothelial insulin signaling seems selective to skeletal muscle arterioles compared with adipose tissue arterioles, perfusion defects are likely to occur first in skeletal muscle tissue during the development of obesity. Moreover, hyperinsulinemia would result in increased sympathetic nervous system activation, which exerts vasodilatation in adipose tissue arterioles, whereas noradrenalin is known to induce vasoconstriction in skeletal muscle arterioles via α-adrenergic receptor stimulation. 68 These distinct regulatory mechanisms regulating perfusion of skeletal muscle and adipose tissue imply that acute overfeeding may redistribute blood flow from skeletal muscle tissue toward adipose tissue, which in turn will affect the delivery of nutrients toward these tissues (Figure) . We hypothesize that this early-prior to insulin resistance occurs in other tissues-and selectiveto skeletal muscle arterioles only-vascular insulin resistance serves as a mechanism favoring storage of excess nutrients in adipose tissue during overfeeding. In turn, the stored nutrients are ready to be released in times of energy deprivation, whereas nutrient storage in AT simultaneously prevents the detrimental effects of ectopic lipid accumulation on peripheral organ function. 69 At this point, our hypothesis is mainly based on modeling data and theoretical arguments, whereas supporting data from human studies are absent. In the next paragraph, we, therefore, elaborate on future perspectives concerning novel research that might help support this hypothesis.
Future Perspectives
Cross-sectional studies that focus on insulin-mediated ATBF and insulin resistance in obese individuals or T2DM patients provide us with associations rather than causative mechanisms. To gain more insight into cause-effect relationships between (impaired) ATBF, weight gain, and whole-body insulin resistance, future studies should focus on intervention studies in animals, and above all in humans. Interventions can include pharmacological strategies to manipulate ATBF, with subsequent assessment of their effects on postprandial glucose and free fatty acid uptake. In addition, clinical studies should focus on the temporal relationship between impaired ATBF and whole-body insulin resistance in diet-induced obesity. We suggest an overfeeding or high-fat diet study in healthy volunteers, in which consecutive measurements of insulin-mediated adipose tissue and skeletal muscle blood flow, glucose uptake, and free fatty acid suppression are performed. Such a study design could in theory also allow detection of differences in the acute effects of the diet on insulin-mediated skeletal muscle perfusion and ATBF, which could strengthen or discard our hypothesis.
Conclusion
Adipose tissue perfusion is linked to its metabolic regulatory function as indicated by rapid changes on food ingestion. Furthermore, in insulin resistance, adipose tissue perfusion is impaired. As such, and in line with the metabolic consequences of vascular dysfunction in skeletal muscle, adipose tissue perfusion defects may also contribute to the development of wholebody insulin resistance. Adipose tissue perfusion defects may reduce delivery of oxygen, lipids, and glucose toward the adipocytes, which may result in hypoxia, ectopic lipid accumulation, and decreased whole-body glucose uptake. However, there are no studies evaluating the temporal relationship between impairments in adipose tissue perfusion and the development of insulin resistance. Therefore, the presence of a causal relationship remains uncertain. In our opinion, it is more likely that adipose tissue serves as an interactive nutrient sink. We speculate that during acute overfeeding, only skeletal muscle blood flow is impaired, while ATBF remains normal, resulting in the redistribution of excess nutrients toward adipose tissue for storage. 
Sources of Funding

Disclosures
None.
